Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (181-190 of 283) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A training-testing approach to the molecular classification of resected non-small cell lung cancerNoboru Yamagata, Yu Shyr, Kiyoshi Yanagisawa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patientsChristine H Chung, Erin H Seeley, Heinrich Roder, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015
Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled AnalysisLuiz H Araujo, Philip E Lammers, Velmalia Matthews-Smith, et al.
Plos One|November 26, 2015
Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing EfficiencyLuiz H Araujo, Cynthia Timmers, Konstantin Shilo, et al.
Cell Reports|July 13, 2022
Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancersKezhong Chen, Airong Yang, David P Carbone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY StudyDaniel Morgensztern, Benjamin Besse, Laurent Greillier, et al.
Cancer Immunology, Immunotherapy : CII|July 31, 2020
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancerMingjia Li, Daniel Spakowicz, Songzhu Zhao, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Science Advances|June 17, 2021
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancersJiefei Han, Ruofei Yu, Jianchun Duan, et al.
The Oncologist|April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with CancerAndrew C Johns, Mike Yang, Lai Wei, et al.
Pageof 29

Showing results (181-190 of 283) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A training-testing approach to the molecular classification of resected non-small cell lung cancerNoboru Yamagata, Yu Shyr, Kiyoshi Yanagisawa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patientsChristine H Chung, Erin H Seeley, Heinrich Roder, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015
Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled AnalysisLuiz H Araujo, Philip E Lammers, Velmalia Matthews-Smith, et al.
Plos One|November 26, 2015
Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing EfficiencyLuiz H Araujo, Cynthia Timmers, Konstantin Shilo, et al.
Cell Reports|July 13, 2022
Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancersKezhong Chen, Airong Yang, David P Carbone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY StudyDaniel Morgensztern, Benjamin Besse, Laurent Greillier, et al.
Cancer Immunology, Immunotherapy : CII|July 31, 2020
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancerMingjia Li, Daniel Spakowicz, Songzhu Zhao, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Science Advances|June 17, 2021
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancersJiefei Han, Ruofei Yu, Jianchun Duan, et al.
The Oncologist|April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with CancerAndrew C Johns, Mike Yang, Lai Wei, et al.
Pageof 29